Industry Presentations

Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype



  • Howard J. Huang, MD

    Howard J. Huang, MD

    Howard J. Huang, MD

    Chief, Section of Lung Transplantation

    Howard J. Huang, MD, is medical director of the lung transplant program at Houston Methodist Lung Transplant Center, J.C. Walter Jr. Transplant Center. Dr. Huang completed his internship and residency in internal medicine at the University of Texas Southwestern Medical Center in Dallas, and a fellowship in pulmonary and critical care medicine at Washington University in St. Louis/Barnes-Jewish Hospital. Dr. Huang recently served as director of lung transplant research and associate medical director of lung transplantation at Baylor University Medical Center in Dallas. One of Dr. Huang’s main focuses is clinical and translational research, with a goal of helping lung transplant patients achieve better long-term outcomes. With a specific interest in interstitial lung diseases, he is involved in the Idiopathic Pulmonary Fibrosis–PROspective Outcomes (IPF-PRO) Registry. Dr. Huang has been an investigator on research grants funded by the National Institutes of Health, the American Thoracic Society, and the International Society for Heart and Lung Transplantation. Currently he is coprincipal investigator on a joint industry and NHLBI study in immunosuppression in lung transplantation.